Clinical Trials 449 Views InDex Pharmaceuticals study has met the primary endpoint Malin Otmani August 29, 2019 The company has announced positive …
Drug Development Pharma 615 Views InDex Pharmaceuticals announces new scientific data Malin Otmani December 7, 2017 InDex Pharmaceuticals Holding has announced …
Intellectual Property 840 Views New patent for InDex Pharmaceuticals Malin Otmani October 11, 2017 InDex Pharmaceuticals Holding announces that …
Intellectual Property 636 Views Index Pharmaceuticals granted patent in Japan Malin Otmani September 13, 2017 The company announces that a …
Clinical Trials 734 Views InDex Pharmaceuticals enrolls first patient in Phase IIb study Malin Otmani June 26, 2017 InDex Pharmaceuticals Holding announces that …
Intellectual Property 823 Views InDex Pharmaceuticals granted patent in the US Malin Otmani March 14, 2017 InDex Pharmaceuticals Holding announces that …
Agreement 1108 Views InDex Pharmaceuticals enters agreement Malin Otmani February 1, 2017 InDex Pharmaceuticals Holding has entered …
Intellectual Property 872 Views InDex Pharmaceuticals gets new patent granted in the US Malin Otmani November 12, 2016 InDex Pharmaceuticals Holding has announced …
Financing 838 Views InDex Pharmaceuticals raises 250 million SEK Malin Otmani September 22, 2016 The Stockholm based company InDex …
Acquisition 744 Views InDex, Almirall S.A End Agreement Ellen R. Delisio July 1, 2015 InDex Pharmaceuticals terminated a license …
In a new job 698 Views InDex Appoints New CEO Ellen R. Delisio February 12, 2015 Peter Zerhouni has been named …
Agreement 731 Views Index Pharmaceuticals signs deal with Almirall Anneli Hidalgo April 1, 2014 The two companies have entered …
